(Q35895845)

11 August 2017

1 reference

title

Dose and response in haemophilia--optimization of factor replacement therapy (English)

1 reference

11 August 2017

0 references

Alok Srivastava

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

British Journal of Haematology

11 August 2017

published in

1 reference

11 August 2017

volume

127

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

12-25

1 reference

Double-blind controlled trial of three dosage regimens in treatment of haemarthroses in haemophilia A

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

A double-blind controlled trial of two dose levels of factor VIII in the treatment of high risk haemarthroses in haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Comparing outcomes of different treatment regimens for severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Discrepancies between genotype and phenotype in hematology: an important frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

HEMOPHILIA--PATHOPHYSIOLOGIC STUDIES AND THE EVOLUTION OF TRANSFUSION THERAPY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Newer approaches to the study of hemophilia and hemophilioid states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Surgery in haemophilia: experience from a centre in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Hemophilia prophylaxis with factor VIII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Home treatment for patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Prophylactic treatment in Sweden--overtreatment or optimal model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Haemophilia prophylaxis in young patients--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Cardiac surgery and catheterization in patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Joint evaluation instruments for children and adults with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Hemophilia: treatment options in the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Use of recombinant factor IX in subjects with haemophilia B undergoing surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Factor replacement for haemophilia--should cryoprecipitate be used?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Low-dose intermittent factor replacement for post-operative haemostasis in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Minimum effective dose of intermediate factor-VIII concentrate in haemophiliacs on home therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Safety and efficacy of high-purity concentrates in haemophiliac patients undergoing surgery by continuous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Prophylaxis in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

The surgical management of intracranial hematomas in hemophiliac children. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

Reproducibility of the Pettersson Scoring System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05110.X

10.1111/J.1365-2141.2004.05110.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference